Clinical Trial Update: Chemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating chemosensitivity testing to guide treatment in patients with stage III or stage IV ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Ovarian Cancer | Phase 3 | Status: COMPLETED